Pulmonary Hypertension

Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Information About COVID-19 for Pulmonary Hypertension Patients - Pulmonary Hypertension News Management of Pulmonary Arterial Hypertension in Patients with Systemi | IBPC - Dove Medical Press Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Posted: 31 Mar 2020 03:28 AM PDT [unable to retrieve full-text content] Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT    MD Linx Information About COVID-19 for Pulmonary Hypertension Patients - Pulmonary Hypertensi...

Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Posted: 31 Mar 2020 03:28 AM PDT [unable to retrieve full-text content] Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT    MD Linx You are subscribed to email updates from "Pulmonary Hypertension" - Google News . To stop receiving these emails, you may unsubscribe now . Email delivery powered by Google Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States

Systemic Sclerosis Mortality High in Asians - MedPage Today Systemic Sclerosis Mortality High in Asians - MedPage Today Posted: 24 Mar 2020 12:01 PM PDT Among patients with system sclerosis (SSc) in Northern California, death came sooner to those of Asian ethnicity than in other groups, a retrospective cohort study found. On a multivariable analysis that adjusted for multiple factors including demographics, disease subtype, and pulmonary or renal involvement, Asian patients with SSc had an increased risk of mortality (HR 1.80, 95% CI 0.99-1.68, P =0.047), according to Lorinda Chung, MD, of Stanford University in California, and colleagues. But all the included minority groups had lower 9-year survival rates than whites, with rates found to be 52.3% in Asians, 52.2% in blacks, and 68.2% in Hispanics compared with 75.8% for whites ( P =0.057), the researchers reported online in ACR Open Rheumatology . Race and ethnicity are recognized as...

Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Posted: 31 Mar 2020 03:28 AM PDT [unable to retrieve full-text content] Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT    MD Linx You are subscribed to email updates from "what is pulmonary hypertension" - Google News . To stop receiving these emails, you may unsubscribe now . Email delivery powered by Google Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States

Management of Pulmonary Arterial Hypertension in Patients with Systemi | IBPC - Dove Medical Press Management of Pulmonary Arterial Hypertension in Patients with Systemi | IBPC - Dove Medical Press Posted: 22 Mar 2020 03:27 PM PDT Saja Almaaitah, 1 Kristin B Highland, 2 Adriano R Tonelli 2 1 Medicine Institute, Cleveland Clinic, Cleveland, OH, USA; 2 Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA Correspondence: Adriano R Tonelli Email tonella@ccf.org Abstract: Systemic sclerosis (SSc) is a rare and complex immune-mediated connective tissue disease characterized by multi-organ fibrosis and dysfunction. Systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is a leading cause of death in this population. Pulmonary arterial hypertension (PAH) can coexist with other forms of pulmonary hypertension in SSc, including pulmonary hypertension related to left heart disease, interstitial lu...

Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT - MD Linx Posted: 31 Mar 2020 03:28 AM PDT [unable to retrieve full-text content] Prognostic factors of pulmonary hypertension associated with connective tissue disease: Pulmonary artery size measured by chest CT    MD Linx Management of Pulmonary Arterial Hypertension in Patients with Systemi | IBPC - Dove Medical Press Posted: 22 Mar 2020 03:27 PM PDT Saja Almaaitah, 1 Kristin B Highland, 2 Adriano R Tonelli 2 1 Medicine Institute, Cleveland Clinic, Cleveland, OH, USA; 2 Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA Correspondence: Adriano R Tonelli Email tonella@ccf.org Abstract: Systemic sclerosi...

Immunosuppressives Seen to Aid SSc-PAH Patient with Rare Antibody - Pulmonary Hypertension News Immunosuppressives Seen to Aid SSc-PAH Patient with Rare Antibody - Pulmonary Hypertension News Posted: 30 Mar 2020 09:00 AM PDT A 62-year-old with systemic sclerosis -associated pulmonary arterial hypertension ( SSc-PAH ) was successfully treated with immunosuppressants and vasodilators, a case study reports. The unusual antibody linked to her disease, called the anticentriole antibody, may also serve as a marker for the use of immunosuppressives in SSc-PAH patients with this antibody. The study, " Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody ," was published in the journal  Case Reports in Rheumatology.   Systemic sclerosis  (SSc), characterized by an overgrowth of connective tissue in the skin and a narrowing of blood vessels, can lead...

Clinical Catch-Up: March 23-27 - BioSpace Clinical Catch-Up: March 23-27 - BioSpace Posted: 30 Mar 2020 06:37 AM PDT The COVID-19 pandemic continues to dominate the news and is likely to for quite some time. The biopharma industry is doing what it can to test and repurpose therapies, develop diagnostics and respond to the crisis. Also, although some clinical trials are being slowed or halted, others are reporting out data. Here's a look. World Health Organization is organizing the SOLIDARITY clinical trial to create data that can be leveraged to decide which treatments are most effective, if they decrease mortality and hospital stays. It will have five arms, one standard of care, one Gilead's remdesivir, one a combination of lopinavir/ritonavir, another a combination of lopinavir/ritonavir/interferon beta, and the fifth of chloroquine. At least 10 countries are participating. Researchers ran a trial of 55 people in China with ...